Company: MDCXW
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001062993-25-011673
Chunk: 88

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 88
---
100,000 per month. Medicus also reimburses RBx for all reasonably necessary and usual business expenses incurred by RBx in connection with the Management Agreement.

Dr. Bokhari is the sole informed person of RBx. On May 3, 2024, Dr. Bokhari subscribed for $300,000 aggregate principal amount of 10.00% Unsecured Convertible Notes due 2025 from the Company on a private placement basis. Dr. Bokhari's 10.00% Unsecured Convertible Notes due 2025 were subsequently converted, along with accrued and unpaid interest, into Common Shares.

<div align='center'>ADDITIONAL INFORMATION</div>

Additional information relating to the Company can be found on the SEC's website at www.sec.gov and on SEDAR+ at www.sedarplus.ca under the Company's issuer profile. Additional financial information is provided in the Company's comparative financial statements and Management Discussion & Analysis for the financial years ended December 31, 2024 and December 31, 2023. A copy of this document and other public documents of the Company are available upon request to 300 Conshohocken State Rd. Suite 200,W. Conshohocken, PA 19428.

<div align='center'>BOARD APPROVAL</div>

The contents and the sending of this proxy statements have been approved by the Board.

<div align='center'>- 65 -

SCHEDULE "A"
AMENDED ARTICLE 3.2 OF BY-LAW NO. 1</div>

3.2 Quorum at Meetings of Shareholders

A quorum for the transaction of business at any meeting of shareholders shall be 2 voting persons holding or representing in the aggregate not less than 33⅓% of the issued and outstanding shares of the Company, or of the class or classes respectively (if there is more than one class of shares outstanding for the time being). Notwithstanding the foregoing, if the Company has only one shareholder, or only one shareholder of any class or series of shares, the shareholder present in person or by proxy constitutes a meeting and a quorum for such meeting.

<div align='center'>SC A-1

SCHEDULE "B"
BOARD MANDATE

MEDICUS PHARMA LTD.
(the "Company")</div>

1.PURPOSE

1.1.The Board of Directors (the "Board") of the Company is responsible for the supervision of the senior management of the business, the going concern and general affairs